Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Date
Custom Date Range
Topic
Content Type

Showing 6461-6480 of 131,260 results

New England Journal Of Medicine Often Ignored Nazi Atrocities, Article Says

April 8, 2024 Morning Briefing

An article in the NEJM criticizes the journal itself for its weak reporting when the Nazis were rising in Germany and performing horrific medical experiments. Also in the news: a probe into liver transplants at Memorial Hermann-Texas Medical Center.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

FDA Should Not Have Approved AvertD Test For Opioid Risk, Experts Say

April 8, 2024 Morning Briefing

A group of 31 experts in genetics, addiction, psychiatry, and medical-device regulation sent letters to the FDA and Centers for Medicare and Medicaid Services, The Washington Post reported. The experts called the approval a mistake that relied on faulty science.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Morning Briefing for Monday, April 8, 2024

April 8, 2024 Morning Briefing

Watch Out For Eye Damage During Today’s Solar Eclipse

April 8, 2024 Morning Briefing

News outlets cover advice on how to avoid eclipse-related retina damage, highlighting the use of special equipment like eclipse glasses — except for the very brief, darkest moments when you’re in the moments of totality. The positive impact of the eclipse is also in the news.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Reveals Abortion Stance After Months Of Dodging Issue

April 8, 2024 Morning Briefing

In a video on social media, former President Donald Trump said it’s “up to the states to do the right thing.” In other news, Republican Wisconsin Senate candidate Eric Hovde appeared to soften his previously strict anti-abortion stance.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

First Edition: April 8, 2024

April 8, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
A photo of a sign with the FDA's logo in front of its headquarters.

Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company

By David Hilzenrath and Holly K. Hacker April 8, 2024 KFF Health News Original

Most of the doctors the FDA tapped to advise it on an Abbott medical device had financial ties to the company. The FDA didn’t disclose the payments.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
A close up photo of a person's hand on computer mouse while they use a laptop on a desk.

Rising Complaints of Unauthorized Obamacare Plan-Switching and Sign-Ups Trigger Concern

By Julie Appleby April 8, 2024 KFF Health News Original

Federal and state regulators are mulling what they can do to thwart this growing problem.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Journalists Assess the Risks of Bird Flu and the Impacts of Medicaid ‘Unwinding’

April 6, 2024 KFF Health News Original

KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

As Republicans Wrestle With IVF, the Biden Administration Expands Benefits

By Michelle Andrews April 5, 2024 KFF Health News Original

While Republican lawmakers try to walk a fine line on in vitro fertilization — expressing support for the popular procedure, even as some of their supporters argue life begins at conception — the federal government expanded fertility benefits for millions of workers this year, including up to $25,000 a year for IVF. Many employers have […]

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Judge: Border Patrol Responsible For Health Of Detained Migrant Kids

April 5, 2024 Morning Briefing

Federal governments must take care of detainees regardless of whether they’ve been formally processed, a federal judge ruled Wednesday. Meanwhile, in Arizona, lawmakers OK’d major reforms for assisted living facilities, with standards enshrined in law.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Longer Looks: Interesting Reads You Might Have Missed

April 5, 2024 Morning Briefing

Each week, KFF Health News finds longer stories for you to enjoy. This week’s selections include stories on alcohol use, palliative care, PANDAS, and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Viewpoints: Here’s The Real Reason Behind High Drug Prices; How Worried Should We Be About Bird Flu?

April 5, 2024 Morning Briefing

Editorial writers tackle pharmaceutical prices, bird flu, the post-Roe situation, and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Tenn. Gov. Sent Bill Requiring Anti-Abortion Group’s Video Shown In Schools

April 5, 2024 Morning Briefing

If signed, Tennessee would become the latest state to require that the “Baby Olivia” video, or equivalent, is watched by public school kids. The video has been criticized as political propaganda, and its accuracy is debated. Separately, a state court is weighing a request to block Tennessee’s abortion ban during pregnancy complications.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

CMS: 2025’s Medicare Advantage Prior Authorization Standards Are Set

April 5, 2024 Morning Briefing

Modern Healthcare says regulators will enhance Medicare Advantage “marketing, prior authorization, and network adequacy standards.” The publication also reports that higher fines are working to make more hospitals disclose pricing.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Opill Contraceptive Covered At Zero Cost For Some By CVS Caremark

April 5, 2024 Morning Briefing

The birth control pill will be added to CVS’ PBM subsidiary’s list of preventive services oral contraceptives so it will be available for free to many plan sponsors. Separately, a new study found over 1 in 8 new mothers said they’d experienced mistreatment during childbirth.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

As Bird Flu Spreads To More Cows, Top Expert Explains Threat To Humans

April 5, 2024 Morning Briefing

“We have never seen this scale of infections in mammals, and in such diversity of mammals,” Dutch virologist Ron Fouchier, a leading expert on H5N1, told STAT. “Adaptation of virus to mammals is not a good thing.”

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Scientists Find Cell-Squeezing Is Clue To Lung Damage From Asthma

April 5, 2024 Morning Briefing

Cells lining the airways can be damaged to destructive levels by constriction caused during an asthma attack, a study found, giving a possible new route to prevent asthma lung damage. Separately, experts warn of a prostate cancer “surge.”

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Hospitals Along Eclipse Path Prepare For Traffic Accidents, Eye Damage

April 5, 2024 Morning Briefing

Though millions of Americans will enjoy the upcoming total eclipse, increased traffic flow and potential “mass casualty events” mean that hundreds of hospitals have to be on high alert. Also in the news: a CPAP replacement, risks from junk food, and more.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Amylyx Pulls ALS Drug From US Market After Study Shows No Benefit

April 5, 2024 Morning Briefing

Amylyx Pharmaceuticals announced Thursday that it is voluntarily halting sales in the U.S. and Canada of Relyvrio, a drug contentiously approved by the FDA for patients with ALS, also known as Lou Gehrig’s disease. A recent clinical trial showed the medicine failed to extend life or improve symptoms.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 322
  • 323
  • 324
  • 325
  • 326
  • Next

More From KFF Health News

Four uniformed U.S. Public Health officers look out of frame.

Public Health Workers Are Quitting Over Assignments to Guantánamo

An aerial view of the wreckage at Unicoi County Hospital after it flooded.

This Ballad Hospital, Flooded by Hurricane Helene, Will Be Rebuilt for $44M in a Flood Plain

Watch: Is MAHA the New MAGA?

An exterior shot of the Hennepin County Medical Center emergency room entrance.

With ICE Using Medicaid Data, Hospitals and States Are in a Bind Over Warning Immigrant Patients

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue